US2970945A

US2970945A - Diagnostic composition

Info

Publication number: US2970945A
Application number: US765065A
Authority: US
Inventors: Alfred H Free; Leonard B Schweiger
Original assignee: Miles Laboratories Inc
Current assignee: Bayer Corp
Priority date: 1958-10-03
Filing date: 1958-10-03
Publication date: 1961-02-07
Anticipated expiration: 1978-02-07

Description

DIAGNGSTIC COMPOSITION Alfred H. Free and'Leonard B. Schweiger, Elkhart, Ind., assignors to Miles Laboratories, Inc, Elkhart, Ind., a corporation of Indiana No Drawing. Filed Oct. 3, 1958, Ser. No. 765,065

-8 Claims. (Cl. 167-845) This invention relates to diagnostic compositions for the detection of gonococci, and is particularly concerned with such compositions in tablet form afiording accurate and convenient means for preparing a solution of oxydase reagent for use in detecting colonies of Neisseria gonorrheae in accordance with the well known oxydase test.

In the oxydase test, the presence of gonococci is determined by incubating genital tract exudate on a Petri plate containing blood agar or some other suitable medium at 37 C. in the presence of increased carbon dioxide tension. At the end of 36 to 48 hours, a freshly prepared solution of p-aminodimethylaniline monohydrochloride is added to the plate and gonococcal colonies quickly assume a characteristic pink color which changes to maroon and finally to black. While the test is fairly simple to perform and provides accurate results when conducted with ordinary care, its popularity has been confined essentially to clinics and other institutional practices where numbers of tests are performed daily, and fresh solutions of the p-arninodimethylaniline monohydrochloride are routinely prepared daily. The test has been readily adaptable to private practice Where, because the aqueous solution of p-aminodimethylaniline monohydrochloride is unstable, it is necessary to prepare a fresh solution at the time each test is to be made, re quiring the expenditure of valuable time by the physician or his technician.

It is an object of the invention to provide a diagnostic composition in tablet form which may be carried conveniently 1n the physicans bag, and which will not deteriorate over long periods of time under ordinary conditions of temperature and humidity, but which may be quickly converted to a solution for use in the oxydase test for gonorrhea simply by dropping a tablet into a measured quantity of water.

Other objects will be apparent from the description of the invention which follows.

A diagnostic composition in accordance with the invention comprises an oxydase reagent, such as p-aminodimethylaniline monohydrochloride or tetramethyl-pphenyleuediamine, and an effervescent couple, the ingredients being intimately mixed in finely divided form, and preferably compressed into tablets of convenient size for use in preparing predetermined quantities of the oxydase solution. The oxydase reagent is the active agent for the test, while the effervescent couple hastens disintegration of the tablet and dissolution of the oxydase reagent when the tablet is dissolved in water. A further function of the effervescent couple is that it provides components which tend to buffer the solution, thereby promoting the reaction of the oxydase reagent with the oxydasepositive colony.

The effervescent couple may be formed from any of a number of solid acids and/or acid-reacting salts in combination with any of the alkali metal carbonates and/or bicarbonates. As the acid component we prefer to use citric acid because it is highly efiicient, stable and Cit 'ice readily available at low cost. However, other acids .or acid reacting substances such as tartaric .acid, alkali metal acid citrates, such as potassium acid citrate, or alkali metal acid sulfates, such as sodium or potassium acid sulfate, may be used instead forthis purpose, if desired.

As the carbonate component of the effervescent couple, we prefer to use sodium bicarbonate, but other water-soluble salts of carbonic acid, including the alkali metal normal carbonates, sesquicarbonates and bicarbonates, e.g. sodium carbonate, sodium sesquicarbonate, or potassium bicarbonate may be 'used instead with satisfactory results.

Example I The following ingredients:

5 grams of p-aminodimethylaniline monohydrochloride 41 grams of citric acid 54 grams of sodium bicarbonate are mixed until a homogeneous mixture of all of the ingredients has been achieved. The mixture is then preferably pressed into tablets of convenient size, e.g., 1000 mg, so that each tablet contains about 50 mg. of paminodimethylaniline monohydrochloride.

In the above example, the acid and carbonate components of the effervescent couple are in substantially stoichiometric proportions. This is the preferred condition, although a slight excess of either the acid or carbonate, to give a pH betWen 6 and 8, is permissible.

When one of the present diagnostic compositions, as represented by the formulation of Example I, is dropped into 10 m1. of water, it efiervesces vigorously during solution due to the reaction between the citric acid and the sodium bicarbonate. The p-aminodimethylaniline monohydrochloride is thus quickly dissolved and is uniformly distributed throughout the solution, which utilizes the bufiering activity of the effervescent couple. After efiervescence ceases, the solution may be added directly to the petri plate where any colonies of gonococci will be detected by the procedure described above.

The proportion of the effervescent couple with respect to the oxydase reagent is not closely critical and may be considerably varied. We prefer to prepare our compositions so that the proportion of the effervescent couple is between about and about 98% of the total weight of the composition. Smaller proportions of the eifervescent couple correspondingly delay solubility of the com position, and larger proportions do not afford any significant advantage in increasing the solubility rate.

Instead of p-aminodimethylaniline monohydrochlo-ride, tetramethyl-p-phenylenediamine may be used as the oxydase reagent, as shown in the following example.

Example ll 5 grams tetramethyl-p-phenylenediamine 41 grams citric acid 54 grams sodium bicarbonate The above ingredients, finely divided, are intimately mixed and preferably pressed into 1000 mg. tablets following the procedure described in Example I.

The p-aminodimethylaniline monohydrochloride is preferred over the tetramethyl-p-phenylenediamine as the oxydase reagent since it is much less expensive and gives tablets of better stability.

What we claim is:

1. As a diagnostic composition, an intimate admixture of dry ingredients consisting essentially of an effervescent couple and a member of the group consisting of p-amino dimethylaniline monohydrochloride and tetramethyl-pr phenylenediamine.

2. A composition in accordance with claim 1 wherein the effervescent couple consists of a Water-soluble salt of 3 carbonic acid and a member of the group consisting of solid acids and acid-reacting salts.

3. A composition in accordance with claim 2 wherein the components of said effervescent couple are present in substantially stoichiomctric quantities.

4. A composition in accordance with claim 3 wherein the proportion of the effervescent couple is between about 85% and about 98% of the total weight of said composition.

5. As a diagnostic composition, an intimate admixture of dry ingredients in tablet form consisting essentially of p-aminodimethylaniline monohydrochloride and an of fervescent couple.

6. A diagnostic composition comprising an intimate admixture, in tablet form, of a minor proportion of paminodimethylaniline monohydrochlo'ride and a major proportion of an effervescent couple consisting essentially of citric acid and sodium bicarbonate.

7. An aqueous solution of the composition claimed in claim 6.

8. A diagnostic composition comprising an intimate admixture, in tablet form, of a minor proportion of tetramethyl-p-phenylenediamine and a major proportion of an effervescent couple consisting essentially of citric acid and sodium bicarbonate.

References Cited in the file of this patent UNITED STATES PATENTS 2,387,244 Compton Oct. 23, 1945 2,799,660 Nicholls July 16, 1957 OTHER REFERENCES Merck Index, Merck and Co., Rahway, N.J., 6th

ed., 1952, pp. 361, 943, 962.

Difco Manual, Difco Lab., Detroit 1, Mich., 9th ed., 1953, pp. 296, 297. r r I y

Claims

1. AS A DIAGNOSTIC COMPOSITION, AN INTIMATE ADMIXTURE OF DRY INGREDIENTS CONSISTING ESSENTIALLY OF AN EFFERVESCENT COUPLE AND A MEMBER OF THE GROUP CONSISTING OF P-AMINODIMETHYLANILINE MONOHYDROCHLORIDE AND TETRAMETYYL-PPHENYLENEDIAMINE.